Impact Biomedical INC.
SEC CIK 1834105 · IBO · last insider filing 2026-03-30
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Grady Jason | Director | filed 2024 - 2026 |
| Chan Heng Fai Ambrose | Director | filed 2024 - 2025 |
| Heuszel Frank D | Director · Chief Executive Officer | filed 2024 - 2024 |
| Sims Melissa Kaye | Director | filed 2024 - 2024 |
| Hibbert Castel Berisford | Director | filed 2024 - 2024 |
| Brownell Elise | Director | filed 2024 - 2024 |
| Zimmerman Christian Thomas | Director | filed 2024 - 2024 |
| Keene David K | Director | filed 2024 - 2024 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Macko Todd D | Chief Financial Officer | filed 2024 - 2026 |
| Suseck Mark | Chief Operating Officer | filed 2024 - 2024 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.